Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A stack of packed moving boxes with a plant on the top. Cyanocapture logo.

CyanoCapture moved into the BioEscalator in November 2021 on a short-term basis after winning the Arctoris Prize at the Oxford Catalyse Biohackathon and securing angel investment to fund its next R&D stage in 2021, as well as winning Elon Musk's Carbon Removal XPRIZE.


The company's mission is to provide affordable, long-term carbon capture on an industrial scale by harnessing genetically modified cyanobacteria. It provides point-source carbon capture to power stations, cement factories and other emission sites. Although the BioEscalator is a medical science incubator, the Management Board was impressed by CyanoCapture and wanted to support its initial phase.


CyanoCapture has moved into the newly refurbished Hayakawa Building at The Oxford Science Park alongside fellow BioEscalator resident Ochre Bio, which has a bespoke chemistry laboratory in the building in addition to its biology lab at the BioEscalator.



It has been helpful to have such a well-organised facility with state-of-the-art working conditions, a vibrant community and regular academic and business-oriented events.

Samir Chitnavis, Co-Founder and CSO at CyanoCapture

CyanoCapture's website